Drugs / Pred
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04928066 Background | Mar 2020 → Jun 2023 | rheumatoid arthritis | Qilu Hospital of Shandong University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pred | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04928066 ↗ |
| Route | Oral | “Pred, 0-10mg, po, once per day (Qd) prescribed if needed and adjusted due to patient response.” NCT04928066 ↗ |